medigraphic.com
ISSN 2395-8723 (Electronic)
ISSN 1405-888X (Print)
TIP Revista Especializada en Ciencias Químico-Biológicas

2007, Number 1

<< Back Next >>

TIP Rev Esp Cienc Quim Biol 2007; 10 (1)

Preparation and in vitro evaluation of biodegradable polymeric nanoparticles as ultrasound contrast agent

Mendoza-Muñoz N, Piñón-Segundo E, Ganem-Quintanar A, Quintanar-Guerrero D

Language: Spanish
References: 24
Page: 14-20
PDF size: 213.04 Kb.


ABSTRACT

Ultrasound contrast agents available in the market do not allow the efficient detection of tumors in diverse organs. The miniaturization of this kind of systems on nanometric scale could solve this problem. The purpose of this work was to adapt the solvent displacement method in order to obtain the “hollow” nanoparticles from the encapsulation of a sublimate nucleus (naphthalene), characterizing them for their size, density and morphology. An in vitro evaluation by means of a commercial ultrasound system was also performed. Nanoparticles with a diameter of 50-400 nm and an entrapment efficiency of 66.55% of naphthalene were obtained. Lyophilization allow to take off 98% of the encapsulated amount of naphthalene, however, the micrographs obtained by scanning electronic microscopy and transmission, did not demonstrate the presence of pores or hollows in the polymeric matrix. In addition, the density of the preparations with naphthalene was similar to the systems with nanospheres formed only by polymer. Nevertheless, in vitro results suggest an increase in echogenicity for those preparations containing nanoparticles, in comparison with those solutions without nanoparticles.


REFERENCES

  1. Lewin, P.A. Quo vadis medical ultrasound? Ultrasonics 42, 1-7 (2004).

  2. Nayaran, P. Development and characterization of hollow polymeric microcapsules for use as contrast agent for diagnostic ultrasound. Ph.D. Thesis, Drexel University (1999).

  3. Morawski, A.M., Lanza, G.A. & Wickline, S.A. Targeted contrast agent for a magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 16, 1-4 (2005).

  4. Gramiak, P.M. & Shah, P.M. Echocardiographic of the aortic root. Invest. Radiol. 3, 356-366 (1968).

  5. Goldberg, B. Contrast agents. Ultrasound Med. Biol. 26, S33-S34 (2000).

  6. Hwang, J., et al. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med. Biol. 31, 553-564 (2005).

  7. Wheatley, M.A. & Oeffinger, B.E. Development and characterization of a nano-scale contrast agent. Ultrasonics 42, 343-347 (2004).

  8. Wheatley, M.A., Forsberg, F., Dube, N., Patel, M. & Oeffinger, B.E. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med. Biol. 32, 83-93 (2006).

  9. Bloch, S.H., Short, R.E., Ferrara, K.W. & Wisner, E.R. The effect of size on the acoustic response of polymer-shelled contrast agents. Ultrasound Med. Biol. 31, 439-444 (2005).

  10. Fessi, H., Devissaguet, J.P. & Puisieux, F. Procéde de préparation de systèmes colloidaux dispersibles d’ une substance, sous forme de nanocapsules. Eur. Patent EP 274 961 (1998).

  11. Quintanar-Guerrero, D., Alléman, E., Fessi, H. & Doelker, E. Preparation and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug. Dev. Ind. Pharm. 24, 1113-1117 (1998).

  12. Leroux, J., Allémann, E., Doelker, E. & Gurny, R. New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur J Pharm Biopharm. 41, 14-18 (1995).

  13. The Merck Index. 17th ed. CD-ROM

  14. El-Sherif, D. & Wheatley, W.A. Development of a novel method for syntesis of a polymeric ultrasound contrast agent. J. Biomed. Mater. Res. 66A, 347- 355 (2003).

  15. Cui, W., et al. Preparation and evaluation of poly(l-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. J. Biomed. Mater. Res. Part B: Appl. Biomater. 73B, 171–178 (2005) .

  16. Straub, J.A., et al. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J. Control. Release 108, 21-32 (2005).

  17. Teixeira, M., Alonso, M.J., Pinto, M.M.M. & Barbosa, C.M. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur. J. Pharm. and Biopharm. 59, 491-500 (2005).

  18. Chawla, J.S. & Amiji, M.M., Biodegradable poly(o-caprolactone) nanoparticles tumor targeted delivery of tamoxifen. Int. J. Pharm. 249, 127-138 (2002).

  19. Goddi, A., et al. In vitro analysis ultrasound second generation contrast agent diluted in saline solution. Radiol. Med. 104, 569-579 (2004).

  20. Bekeredjian, R., et al. Potential of gold-bound microtubules as a new ultrasound contrast agent. Ultrasound Med. Biol. 28, 691-695 (2002).

  21. Jong, N., Hoff, L., Skotland, T. & Born, N. Absorption and scatter of encapsulated gas filled microspheres: Theoretical considerations and some measurements. Ultrasonics 30, 95-103 (1992).

  22. Wheatley, M.A. & Oeffinger, B.E. Development and characterization of a nano-scale contrast agent. Ultrasonics 42, 343-347 (2004).

  23. Couture, O., et al. Investigating perfluorohexane particles with highfrequency ultrasound. Ultrasound Med. Biol. 32, 73-82 (2006).

  24. Wheatley, M.A., Forsberg, F., Dube, N., Patel, M. & Oeffinger, B.E. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound Med. Biol. 32, 83-93 (2006).




2020     |     www.medigraphic.com